TABLE 1.
Characteristics of 176 patients with hematological malignancies
| Characteristic | Number (%) |
|---|---|
| Number of patients | 176 |
| Disease type | |
| AML | 22 (13) |
| ALL/LBL | 29 (16) |
| ALAL | 4 (2) |
| BPDCN | 4 (2) |
| MPN | 11 (6) |
| MDS/MPN | 3 (2) |
| MDS | 6 (3) |
| B‐NHL | 51 (29) |
| T/NK‐NHL | 32 (18) |
| HL | 1 (1) |
| MM | 11 (6) |
| Others | 2 (1) |
| Sex | |
| Male | 111 (63) |
| Female | 65 (37) |
| Age, years | |
| 0–14 | 14 (8) |
| 15–39 | 39 (22) |
| 40–64 | 61 (35) |
| ≥65 | 62 (35) |
| Disease status | |
| Primary | 104 (59) |
| Relapsed/refractory | 72 (41) |
Abbreviations: ALAL, acute leukemias of ambiguous lineage; ALL/LBL, acute lymphoblastic leukemia/lymphoblastic lymphoma; AML, acute myeloid leukemia; B‐NHL, B‐cell non‐Hodgkin lymphoma; BPDCN, blastic plasmacytoid dendritic cell neoplasm; HL, Hodgkin lymphoma; MDS, myelodysplastic syndrome; MM, multiple myeloma; MPN, myeloproliferative neoplasm; T/NK‐NHL, T/natural killer‐cell non‐Hodgkin lymphoma.